Page last updated: 2024-11-02

phenylbutazone and Hemochromatosis

phenylbutazone has been researched along with Hemochromatosis in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorfmann, H1
Solnica, J1
Mitrovic, D1
Dreyfus, P1

Other Studies

1 other study available for phenylbutazone and Hemochromatosis

ArticleYear
[Changes of bones and joints in hemochromatosis].
    Munchener medizinische Wochenschrift (1950), 1969, Jun-20, Volume: 111, Issue:25

    Topics: Arthritis, Rheumatoid; Bone and Bones; Bone Diseases; Calcinosis; Cartilage Diseases; Colchicine; Co

1969